News Conference News AHA 2018 AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City Shelley Wood November 05, 2018
News Features The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine Shelley Wood October 22, 2018
News Daily News New-Onset A-fib Following Noncardiac Surgery: Beware the Thromboembolic Risk Yael L. Maxwell October 16, 2018
News Daily News Patients With A-fib and Cancer May Benefit From Visiting With a Cardiologist Early On Todd Neale October 10, 2018
News Daily News DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus Caitlin E. Cox October 04, 2018
News Daily News Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms Todd Neale October 03, 2018
News Conference News TCT 2018 OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients Todd Neale September 24, 2018
News Conference News ESC 2018 New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All Michael O'Riordan August 29, 2018
News Conference News ESC 2018 Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI Michael O'Riordan August 25, 2018
News Daily News Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks Todd Neale August 13, 2018
News Daily News New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI Michael O'Riordan July 31, 2018
News Daily News Asian Patients With A-fib Don’t Gain Anything From Low-Dose Rivaroxaban Todd Neale July 24, 2018
News Daily News NOACs Particularly Beneficial for Women With A-fib, Study Suggests Todd Neale July 11, 2018
News Daily News Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis L.A. McKeown July 10, 2018
News Daily News Oral Anticoagulation Boosts Poststroke Outcomes in Patients With A-fib Todd Neale May 18, 2018
News Conference News HRS 2018 CABANA Misses Primary Endpoint, but Electrophysiologists See Support for Ablation Todd Neale May 10, 2018
News Daily News Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval Todd Neale May 04, 2018
News Conference News SCAI 2018 Doctors, Risk Tools Often at Odds When Assessing Risks in Patients With A-fib Undergoing PCI Todd Neale April 27, 2018
News Conference News ACC 2018 Reversal Agent for Factor Xa Inhibitors Continues to Look Good: ANNEXA-4 Todd Neale March 13, 2018